ArticleScientific reports2023

Efficacy of elotuzumab for multiple myeloma in reference to lymphocyte counts and kappa/lambda ratio or B2 microglobulin.

Yutaka Shimazu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.